 I. Obtain quantitative measurements in various body regions of standardized uptake values SUV in normal tissue and foci of pathologic tracer uptake in PETMRI of pediatric patients with oncologic disease using various magnetic resonance attenuation correction MRAC methods and compare those to respective SUV based on CT attenuation correction. 